Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Health
William Ton

New hope for Aussies battling early stage breast cancer

The government is expanding subsidies for Verzenio for women living with early stage breast cancer. (Supplied/AAP PHOTOS)

Australians who live with a high risk of recurrence after early breast cancer will soon pay as little as $7.70 for an expanded treatment that could halt the disease from spreading.

The federal government is expanding subsidies for abemaciclib (Verzenio) for an additional 2400 Australians living with early stage breast cancer that has not yet spread beyond the area but has a high risk of doing so.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.